GlucoTrack Statistics
Total Valuation
GlucoTrack has a market cap or net worth of $12.31 million. The enterprise value is $8.00 million.
| Market Cap | 12.31M |
| Enterprise Value | 8.00M |
Important Dates
The next estimated earnings date is Monday, May 6, 2024, before market open.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GlucoTrack has 26.76 million shares outstanding. The number of shares has increased by 34.16% in one year.
| Shares Outstanding | 26.76M |
| Shares Change (YoY) | +34.16% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | 34.75% |
| Owned by Institutions (%) | 8.53% |
| Float | 15.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.22, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.22 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 1,014.86 |
Financial Efficiency
Return on equity (ROE) is -172.00% and return on invested capital (ROIC) is -209.37%.
| Return on Equity (ROE) | -172.00% |
| Return on Assets (ROA) | -127.10% |
| Return on Capital (ROIC) | -209.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.18M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.65% in the last 52 weeks. The beta is 0.30, so GlucoTrack's price volatility has been lower than the market average.
| Beta (1Y) | 0.30 |
| 52-Week Price Change | -16.65% |
| 50-Day Moving Average | 0.38 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 47.80 |
| Average Volume (30 Days) | 175,933 |
Short Selling Information
The latest short interest is 106,156, so 0.40% of the outstanding shares have been sold short.
| Short Interest | 106,156 |
| Short Previous Month | 98,130 |
| Short % of Shares Out | 0.40% |
| Short % of Float | 0.68% |
| Short Ratio (days to cover) | 0.88 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.10M |
| Pretax Income | -7.10M |
| Net Income | -7.10M |
| EBITDA | -7.09M |
| EBIT | -7.10M |
| Earnings Per Share (EPS) | -$0.38 |
Balance Sheet
The company has $4.50 million in cash and $196,000 in debt, giving a net cash position of $4.31 million or $0.16 per share.
| Cash & Cash Equivalents | 4.50M |
| Total Debt | 196,000 |
| Net Cash | 4.31M |
| Net Cash Per Share | $0.16 |
| Equity / Book Value | 3.20M |
| Book Value Per Share | 0.12 |
| Working Capital | 3.36M |
Cash Flow
| Operating Cash Flow | -6.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.56M |
| FCF Per Share | -$0.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GlucoTrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.16% |
| Shareholder Yield | -34.16% |
| Earnings Yield | -57.66% |
| FCF Yield | -53.28% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 13, 2021. It was a reverse split with a ratio of 1:13.
| Last Split Date | Aug 13, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:13 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |